{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:04:24Z","timestamp":1784714664722,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Reports"],"abstract":"<jats:p>Systemic primary carnitine deficiency (SPCD) is an autosomal recessive inborn error of fatty acid metabolism caused by a defect in the transporter responsible for moving carnitine across plasma membrane. The clinical features of SPCD vary widely based on the age of onset and organs involved. During infancy, patients might show episodes of hypoketotic hypoglycemia, hepatomegaly, elevated transaminases, and hyperammonemia. Skeletal myopathy, elevated creatine kinase, and cardiomyopathy are the main manifestations in children with SPCD, while in adults, the disorder is usually manifested as cardiomyopathy, arrhythmias, or fatigability. Here, we report a 5-year-old boy with SPCD that presented as dilated cardiomyopathy with atypical features, such as anemia, respiratory distress, and proximal muscle weakness. This report supports considering carnitine deficiency treatment in the work-up of unexplained pediatric dilated cardiomyopathy.<\/jats:p>","DOI":"10.4081\/pr.2018.7705","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T10:05:17Z","timestamp":1531476317000},"page":"7705","source":"Crossref","is-referenced-by-count":1,"title":["A Case of Atypical Systemic Primary Carnitine Deficiency in Saudi Arabia"],"prefix":"10.3390","volume":"10","author":[{"given":"Abdulrahman","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Shawli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf","family":"Waggass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"ref1","first-page":"134","article-title":"Primary and secondary disorders of carnitine metabolism","volume":"5","author":"De Vivo","year":"1990","journal-title":"Int Pediatr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"Flanagan","year":"2010","journal-title":"Nutr Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0272-6386(03)00112-4","article-title":"The role of carnitine in normal and altered fatty acid metabolism","volume":"41","author":"Hoppel","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4070\/kcj.2013.43.12.785","article-title":"Primary carnitine deficiency and cardiomyopathy","volume":"43","author":"Fu","year":"2013","journal-title":"Korean Circ J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1006\/bbrc.1999.1060","article-title":"Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality","volume":"261","author":"Burwinkel","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.96.5.2356","article-title":"Mutations in the organic cation\/carnitine transporter OCTN2 in primary carnitine deficiency","volume":"96","author":"Wang","year":"1999","journal-title":"Proceed Natl Acad Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1797.2007.00817.x","article-title":"L-carnitine supplementation in the dialysis population: Are Australian patients missing out?","volume":"13","author":"Reuter","year":"2008","journal-title":"Nephrology"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","author":"Longo","year":"2006","journal-title":"Wiley Online Library: Am J Med Genet Part C: Seminars in Medical Genetics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1750-1172-7-68","article-title":"Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management","volume":"7","author":"Magoulas","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00246-007-9051-9","article-title":"Carnitine membrane transporter deficiency: a rare treatable cause of cardiomyopathy and anemia","volume":"29","author":"Cano","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00125817-200111000-00002","article-title":"Phenotype and genotype variation in primary carnitine deficiency","volume":"3","author":"Wang","year":"2001","journal-title":"Genet Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000107675","article-title":"A case of early diagnosed carnitine deficiency presenting with respiratory symptoms","volume":"51","author":"Erguven","year":"2007","journal-title":"Ann Nutr Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/8904_2011_52","article-title":"Primary carnitine deficiency presents atypically with long QT syndrome: a case report","volume":"2","author":"De Biase","year":"2012","journal-title":"JIMD Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/0256-4947.65254","article-title":"Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008","volume":"30","author":"Moammar","year":"2010","journal-title":"Ann Saudi Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-016-0510-3","article-title":"Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia","volume":"11","author":"Alfadhel","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1023\/B:BOLI.0000037339.25821.87","article-title":"OCTN2 mutation (R254X) found in Saudi Arabian kindred: Recurrent mutation or ancient founder mutation?","volume":"27","author":"Lamhonwah","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1020143632011","article-title":"Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency","volume":"25","author":"Rahbeeni","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pediatrneurol.2014.05.015","article-title":"Hereditary neurometabolic causes of infantile spasms in 80 children presenting to a tertiary care center","volume":"51","author":"Alrifai","year":"2014","journal-title":"Pediatr Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.10585","article-title":"Novel OCTN2 mutations: no genotype\u2013phenotype correlations: early carnitine therapy prevents cardiomyopathy","volume":"111","author":"Lamhonwah","year":"2002","journal-title":"Am J Med Genet Part A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/8904_2014_312","article-title":"Carnitine profile and effect of suppletion in children with renal Fanconi syndrome due to cystinosis","volume":"16","author":"Besouw","year":"2014","journal-title":"JIMD Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/humu.21607","article-title":"Genotype-phenotype correlation in primary carnitine deficiency","volume":"33","author":"Rose","year":"2012","journal-title":"Hum Mutat"},{"key":"ref23","article-title":"Encyclopedia of molecular mechanisms of disease","author":"Lang","year":"2009","journal-title":"Springer Science & Business Media"},{"key":"ref24","first-page":"59","article-title":"L-carnitine in children with idiopathic dilated cardiomyopathy","volume":"50","author":"Kothari","year":"1998","journal-title":"Indian Heart J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.105.6.1260","article-title":"Metabolic aspects of myocardial disease and a role forl-carnitine in the treatment of childhood cardiomyopathy","volume":"105","author":"Helton","year":"2000","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.ijcard.2011.11.010","article-title":"Thirty-year follow-up of carnitine supplementation in two siblings with hypertrophic cardiomyopathy caused by primary systemic carnitine deficiency","volume":"159","author":"Kishimoto","year":"2012","journal-title":"Int J Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ijcard.2012.05.038","article-title":"Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up","volume":"162","author":"Agnetti","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref28","first-page":"169","article-title":"Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study","volume":"28","author":"El Mouzan","year":"2008","journal-title":"Ann Saudi Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jpc.13469","article-title":"Expanded newborn screening program in Saudi Arabia: Incidence of screened disorders","volume":"53","author":"Alfadhel","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1067\/mpd.2001.111813","article-title":"Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry","volume":"138","author":"Wilcken","year":"2001","journal-title":"J Pediatr"}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/pr\/article\/viewFile\/7705\/7376","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2036-7503\/10\/2\/7705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:58:14Z","timestamp":1720418294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/10\/2\/7705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["pr.2018.7705"],"URL":"https:\/\/doi.org\/10.4081\/pr.2018.7705","relation":{},"ISSN":["2036-7503"],"issn-type":[{"value":"2036-7503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]}}}